1. Home
  2. MNKD vs SCL Comparison

MNKD vs SCL Comparison

Compare MNKD & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • SCL
  • Stock Information
  • Founded
  • MNKD 1991
  • SCL 1932
  • Country
  • MNKD United States
  • SCL United States
  • Employees
  • MNKD N/A
  • SCL N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • SCL Package Goods/Cosmetics
  • Sector
  • MNKD Health Care
  • SCL Consumer Discretionary
  • Exchange
  • MNKD Nasdaq
  • SCL Nasdaq
  • Market Cap
  • MNKD 1.4B
  • SCL 1.3B
  • IPO Year
  • MNKD 2004
  • SCL N/A
  • Fundamental
  • Price
  • MNKD $3.77
  • SCL $53.82
  • Analyst Decision
  • MNKD Buy
  • SCL
  • Analyst Count
  • MNKD 4
  • SCL 0
  • Target Price
  • MNKD $9.75
  • SCL N/A
  • AVG Volume (30 Days)
  • MNKD 2.6M
  • SCL 108.5K
  • Earning Date
  • MNKD 08-06-2025
  • SCL 07-30-2025
  • Dividend Yield
  • MNKD N/A
  • SCL 2.87%
  • EPS Growth
  • MNKD 228.27
  • SCL 47.62
  • EPS
  • MNKD 0.10
  • SCL 2.45
  • Revenue
  • MNKD $297,595,000.00
  • SCL $2,222,111,000.00
  • Revenue This Year
  • MNKD $13.72
  • SCL $9.02
  • Revenue Next Year
  • MNKD $15.21
  • SCL $6.65
  • P/E Ratio
  • MNKD $36.35
  • SCL $21.95
  • Revenue Growth
  • MNKD 32.50
  • SCL N/A
  • 52 Week Low
  • MNKD $3.63
  • SCL $44.23
  • 52 Week High
  • MNKD $7.63
  • SCL $94.77
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 34.62
  • SCL 46.58
  • Support Level
  • MNKD $3.63
  • SCL $53.49
  • Resistance Level
  • MNKD $3.85
  • SCL $55.26
  • Average True Range (ATR)
  • MNKD 0.15
  • SCL 1.23
  • MACD
  • MNKD -0.02
  • SCL -0.25
  • Stochastic Oscillator
  • MNKD 16.47
  • SCL 20.56

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Share on Social Networks: